New CDK strategies could target tumor growth by shutting down key gene activity
Cancer is the second-leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come ...
Aug 24, 2026
0
3









